Literature DB >> 19358280

Molecular variants of HPV-16 associated with cervical cancer in Indian population.

M R Pillai1, R Hariharan, Janki Mohan Babu, S Lakshmi, S V Chiplunkar, M Patkar, H Tongaonkar, K Dinshaw, R S Jayshree, B K M Reddy, M Siddiqui, Soma Roychoudury, Baisakhi Saha, P Abraham, M Gnanamony, A Peedicayil, J Subhashini, T S Ram, Bindu Dey, C Sharma, S K Jain, N Singh.   

Abstract

Human papilloma virus is a causative factor in the etiology of cervical cancer with HPV16 being the most prevalent genotype associated with it. Intratype variations in oncogenic E6/E7 and capsid L1 proteins of HPV 16 besides being of phylogenetic importance, are associated with risk of viral persistence and progression. The objective of this multicentric study was to identify HPV-16 E6, E7 and L1 variants prevalent in India and their possible biological effects. Squamous cell cervical cancer biopsies were collected from 6 centres in India and examined for the presence of HPV 16. Variants of HPV-16 were characterized by full length sequence analysis of L1, E6 and E7 genes in 412 samples. Similar distribution of the variants was seen from the different centres/regions, with the European variant E350G being the most prevalent (58%), followed by American Asian variant (11.4%). Fifty six changes were seen in E6 region, 31 being nonsynonymous. The most frequent being L83V (72.3%), Q14H (13.1%) and H78Y (12.1%). Twenty-nine alterations were seen in E7 region, with 12 being nonsynonymous. The most frequent being F57V (9%). L1 region showed 204 changes, of which 67 were nonsynonymous. The most frequent being 448insS (100%), and 465delD (100%), H228D (94%), T292A (85%). The identified variants some new and some already reported can disrupt pentamer formation, transcriptional regulation of the virus, L1 protein interface interaction, B and T cell epitopes, p53 degradation, and thus their distribution is important for development of HPV diagnostics, vaccine, and for therapeutic purpose.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19358280     DOI: 10.1002/ijc.24322

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  Autophagy knocked down by high-risk HPV infection and uterine cervical carcinogenesis.

Authors:  Xueli Li; Zhengyuan Gong; Linglin Zhang; Chen Zhao; Xianda Zhao; Xin Gu; Honglei Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  HPV types and variants among cervical cancer tumors in three regions of Tunisia.

Authors:  Keris KrennHrubec; Karima Mrad; Badreddine Sriha; Farhat Ben Ayed; Danielle M Bottalico; Janae Ostolaza; Benjamin Smith; Tatyana Tchaikovska; Amr S Soliman; Robert D Burk
Journal:  J Med Virol       Date:  2011-04       Impact factor: 2.327

3.  Genetic analysis of human papilloma virus 16 E6/E7 variants obtained from cervical cancer cases in Chhattisgarh, a central state of India.

Authors:  Sanjay Singh Negi; Kuldeep Sharma; Divakar Sharma; Pushpendra Singh; Pragya Agarwala; Nighat Hussain; Anudita Bhargava; Padma Das; Sarita Agarwal
Journal:  Virusdisease       Date:  2021-07-26

4.  Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties.

Authors:  Mahboobeh Safaeian; Koenraad van Doorslaer; Mark Schiffman; Zigui Chen; Ana Cecilia Rodriguez; Rolando Herrero; Allan Hildesheim; Robert D Burk
Journal:  Arch Virol       Date:  2010-01-06       Impact factor: 2.574

5.  Human papillomavirus (HPV) 16 E6 variants in tonsillar cancer in comparison to those in cervical cancer in Stockholm, Sweden.

Authors:  Juan Du; Cecilia Nordfors; Anders Näsman; Michal Sobkowiak; Mircea Romanitan; Tina Dalianis; Torbjörn Ramqvist
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  Genetic variability and phylogeny of high risk HPV type 16, 18, 31, 33 and 45 L1 gene in Greek women.

Authors:  Chara Kleio Ntova; Christine Kottaridi; Aikaterini Chranioti; Aris Spathis; Dimitrios Kassanos; Evangelos Paraskevaidis; Petros Karakitsos
Journal:  Int J Mol Sci       Date:  2011-12-22       Impact factor: 5.923

7.  Detecting Human Papillomavirus Type 16 in Cervical Cancer Patients with Molecular Variation of Gene L1 in Riau Province Indonesia.

Authors:  Maya Savira; Donel S; Andani Eka Putra; Yusrawati Yusrawati; Nur Indrawati Lipoeto
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

8.  Prevalence of human papillomavirus variants and genetic diversity in the L1 gene and long control region of HPV16, HPV31, and HPV58 found in North-East Brazil.

Authors:  Ana Pavla Almeida Diniz Gurgel; Bárbara Simas Chagas; Carolina Medeiros do Amaral; Kamylla Conceição Gomes Nascimento; Lígia Rosa Sales Leal; Jacinto da Costa Silva Neto; Maria Tereza Cartaxo Muniz; Antonio Carlos de Freitas
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

9.  Prevalence and genetic variability in capsid L1 gene of rare human papillomaviruses (HPV) found in cervical lesions of women from North-East Brazil.

Authors:  Ana Pavla Almeida Diniz Gurgel; Bárbara Simas Chagas; Carolina Maria Medeiros do Amaral; Eugênia Maria Bezerra Albuquerque; Ivi Gonçalves Soares Santos Serra; Jacinto da Costa Silva Neto; Maria Tereza Cartaxo Muniz; Antonio Carlos de Freitas
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

10.  Long-term follow-up of HPV16-positive women: persistence of the same genetic variant and low prevalence of variant co-infections.

Authors:  Daan T Geraets; Leen-Jan van Doorn; Bernhard Kleter; Brigitte Colau; Diane M Harper; Wim G V Quint
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.